Summit Therapeutics Inc. Ratios

Ratios Jan2013 Jan2014 Jan2015 Jan2016 Jan2017 Jan2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -240.95%-366.72%49,510.01%0.81%-1,115.76%-236.91%15.91%-3,915.34%-6,152.33%-4,897.84%-11,174.75%3,977.54%2,701.87%
EBIT Margin -241.53%-367.21%47,760.90%707.02%-1,078.69%-259.06%9.44%-3,697.58%-6,185.23%-4,764.29%-10,225.39%3,943.40%2,601.87%
EBITDA Margin -222.96%-367.21%44.20%0.70%-0.93%-259.06%18.17%-3,913.32%-6,014.77%-4,809.56%-11,131.63%3,981.13%2,546.07%
Operating Margin -241.53%-367.21%47,760.90%707.02%-1,078.69%9.44%-3,697.58%-6,185.23%-4,764.29%-10,225.39%3,943.40%2,601.87%
Net Margin -240.95%-366.72%49,510.01%0.81%-1,115.76%-236.91%19.04%-3,920.19%-6,127.56%-4,897.84%-11,174.75%3,977.54%2,701.87%
FCF Margin -240.95%-366.72%49,510.01%648.05%523.44%865.80%-61.77%-2,821.27%-5,643.26%-4,029.46%-5,986.67%497.34%1,637.64%
Efficiency
Assets Average 0.09B0.10B0.11B0.39B0.43B0.32B
Equity Average 0.08B0.08B0.10B0.10B0.23B
Invested Capital 0.01B0.01B0.09B0.08B0.08B0.13B0.08B0.39B
Asset Utilization Ratio 0.010.010.020.00-0.04-0.03
Leverage & Solvency
Interest Coverage Ratio 0.00B-7.07-28.8311.69-8.6994.37-16.38-37.04-26.02
Debt to Equity 0.003.901.29
Debt Ratio -0.11-0.140.000.740.49
Equity Ratio 0.820.780.730.190.380.89
Times Interest Earned 0.00B-7.07-28.8311.69-8.6994.37-16.38-37.04-26.02
Valuation
Enterprise Value 0.11B0.09B0.17B0.02B-0.01B0.32B0.19B0.21B1.64B12.75B
Market Capitalization 0.11B0.13B0.06B0.05B0.39B0.26B0.86B1.83B13.16B
Return Ratios
Return on Sales -2.41%-3.67%495.10%0.01%-11.16%-2.37%0.19%-39.20%-61.28%-48.98%-111.75%39.78%27.02%
Return on Capital Employed -0.37%-0.67%-1.05%-0.21%-1.48%-0.81%
Return on Invested Capital -0.63%
Return on Assets -0.33%-0.53%-0.82%-0.20%-1.42%-0.74%
Return on Equity -0.67%-1.09%-0.75%-6.02%-1.01%